| - Industry | - Sector | Mr. Joseph Pandolfino MBA CEO | OTCQX Exchange | - ISIN |
| US Country | 5 Employees | - Last Dividend | - Last Split | - IPO Date |
Cabbacis Inc. is a development stage company that is focused on the innovative field of modified risk tobacco products. Established in 2023 and headquartered in Niagara Falls, New York, the company aims to transform the tobacco market by offering alternatives that reduce health risks associated with traditional tobacco consumption. Cabbacis Inc. is actively developing its product offerings to capture markets across various regions including the United States, Canada, Mexico, Brazil, Europe, the United Kingdom, Switzerland, China, Russia, India, Japan, South Korea, Indonesia, the Philippines, Australia, New Zealand, and other countries. The company is positioned for significant growth as it explores the potential of its unique products designed to meet consumer demands in the evolving tobacco landscape.
Cabbacis Inc. is focused on the development of modified risk tobacco products which aim to deliver a safer alternative to traditional cigarettes. These products are designed to reduce the harmful effects commonly associated with smoking, providing consumers with options that align with evolving health regulations and preferences.
Under the iBlend brand, Cabbacis Inc. is innovatively developing a new line of cigarettes aimed at reducing the health risks associated with conventional smoking. These products incorporate advanced technology and unique formulations to appeal to a health-conscious demographic.
The company is also in the process of creating vaporizer pods designed for oral electronic vaporizers. These pods are set to provide a satisfying vapor experience while minimizing exposure to harmful substances, making them an attractive option for consumers looking to reduce their tobacco-related health risks.